MedWatch

Karo chairman on million-dollar acquisition: Prepares us for further European growth

With the acquisition of Swedish Trimb, the chairman of Karo Pharma sets out to realize the goal of becoming Northern Europe's leading specialty pharma company.

Foto: Ritzau Scanpix/STF/Thomas Lekfeldt

Danish biotech billionaire Bo Jesper Hansen has not wasted time since he took position as chairman of Swedish Karo Pharma in February.

First, he worked out a strategy for the company, then he got former Shire CEO Flemming Ørnskov into the board and shortly after, he appointed Christoffer Lorenzen as CEO.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier